Pre-eclampsia. Pre-eclampsia
Conditions
Interventions
Intervention 1: Intervention group: The first group uses a gram of an EPA with DHA as an omega-3 pearl until the end of pregnancy. Intervention 2: Control group: The control group received the placebo
Sponsors
Gorgan University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 40 Years
Inclusion criteria
Inclusion criteria: nulliparous Pregnant women with 14 to 18 weeks gestational age Satisfaction to participate in the study Women without a high risk of preeclampsia (age under 20 and over 40 years, history of preeclampsia in a previous pregnancy or in the family, twins pregnancy, body mass index equal or greater than 29, kidney disease and hypertension ) Do not use calcium, aspirin, anticoagulants and insulin No history of allergy to omega-3 20 to 40 years old
Exclusion criteria
Exclusion criteria: Unwillingness to cooperate Forced to use aspirin, calcium and heparin during the study Not being able to continue taking medication due to digestive problems or because of an allergic reaction Women with a high risk of preeclampsia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pre-eclampsia Prevalence in Nulliparous Pregnant Women. Timepoint: From the beginning of the study to the end of pregnancy. Method of measurement: Pressure gauge and criteria for diagnosis of pre-eclampsia. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr Sara Shafiee
Gorgan University of Medical Sciences
Outcome results
None listed